UK Markets open in 5 hrs 49 mins

Centessa Pharmaceuticals Limited (CNTA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.85-1.15 (-8.85%)
At close: 04:00PM EST
11.85 0.00 (0.00%)
After hours: 05:24PM EST
Full screen
Loading interactive chart…
  • Zacks

    Centessa Pharmaceuticals (CNTA) Sees Hammer Chart Pattern: Time to Buy?

    Centessa Pharmaceuticals (CNTA) has been struggling lately, but the selling pressure may be coming to an end soon.

  • Globe Newswire

    Centessa Pharmaceuticals Announces Third Quarter 2021 Financial Results and Business Updates

    ~ Announced positive topline data from proof-of-concept study of SerpinPC in severe hemophilia A and B subjects not on prophylaxis, demonstrating 88% reduction in median Annualized Bleeding Rate (“ABR”) for all bleeds and 94% reduction in median ABR for spontaneous joint bleeds in highest dose tested ~ ~ Announced proof-of-mechanism data from first three PiMZ subjects dosed in Phase 1 Part B study evaluating ZF874 for the treatment of Alpha-1 Antitrypsin Deficiency (“AATD”) ~ ~ Announced collabo

  • Globe Newswire

    Centessa Pharmaceuticals to Present at Upcoming Conferences in 2021

    BOSTON and LONDON, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (“Company”) (Nasdaq: CNTA) today announced that Saurabh Saha, MD, PhD, Chief Executive Officer, will present at the following investor conferences: Event: Jefferies London Healthcare Conference Date: Thursday, November 18, 2021Presentation Details: Recording available on-demand on Thursday, November 18, 2021, starting at 3:00 AM ET (8:00 GMT) Event: Evercore ISI HealthCONx Conference Date: Thursday, December 2, 202